Cost-effectiveness of screening for asymptomatic left ventricular dysfunction in childhood cancer survivors.
Richard M
RM
Steingart
Jennifer E
JE
Liu
Kevin C
KC
Oeffinger
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D004452:Echocardiography / Q000191:economics*; D005260:Female; D006333:Heart Failure / Q000517:prevention & control*; D006801:Humans; D008297:Male; D009369:Neoplasms / Q000150:complications*; D017410:Practice Guidelines as Topic; D018487:Ventricular Dysfunction, Left / Q000000981:diagnostic imaging*
D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors